首页> 外文期刊>Clinical, Cosmetic and Investigational Dermatology >Epidermolytic hyperkeratosis: clinical update
【24h】

Epidermolytic hyperkeratosis: clinical update

机译:表皮溶解性角化过度:临床更新

获取原文
           

摘要

Epidermolytic hyperkeratosis (EHK), earlier termed as bullous congenital ichthyosiform erythroderma is a skin disorder characterized as an autosomal dominant and rare disorder which has been observed to affect 1 in over 200,000 infants as a consequence of a significant mutation in the genes responsible for the keratin proteins, mostly keratin 1 and 10. The features present at birth include erythema and blistering. In adults, the hallmarks include hyperkeratosis, erosions, and blisters. The major symptoms including xerosis, pruritus, and painful fissuring lead not only to cosmetic problems but also stress, inferiority complex and other psychological conditions. While clinical inspection followed by confirmatory tests including histopathology and electron microscopic assessment is used for diagnosis, treatment modalities can be further improved for better diagnosis. This article reviews subtypes of ichthyosis, with a focus on EHK, genetics behind the disease, recently reported mutations, the existing diagnostics and treatments for the same and potential of new modalities in diagnosis/treatment.
机译:皮肤表皮过度角化病(EHK),先前称为大疱性先天性鱼鳞状红皮病,是一种以常染色体显性和罕见病为特征的皮肤病,由于负责角蛋白的基因发生重大突变,已观察到影响200,000婴儿中的1名蛋白质,主要是角蛋白1和10。出生时出现的特征包括红斑和水疱。在成年人中,特征包括角化过度,糜烂和水泡。包括干燥症,瘙痒和痛苦的裂痕在内的主要症状不仅会导致美容问题,还会导致压力,自卑感和其他心理状况。虽然将临床检查后再进行包括组织病理学和电子显微镜评估在内的确证性检查用于诊断,但可以进一步改善治疗方式以更好地进行诊断。本文回顾了鱼鳞病的亚型,重点是EHK,该病的遗传学,最近报道的突变,与之相同的潜力的诊断方法和治疗方法以及新的诊断/治疗方法的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号